Belgian startup revives Galapagos CAR-T research

T2Covered by 1 source · first reported by BioPharma Dive / Healthcare Dive / MedTech Dive at 15 Oct, 15:55 UTC

Armed Cell Therapeutics, chaired by former Galapagos CEO Paul Stoffels, has assumed control of cell therapies the company — now known as Lakefront Biotherapeutics — divested in a strategic overhaul.